147 related articles for article (PubMed ID: 37530986)
1. Utilization of opportunistic cervical cancer screening in Nigeria.
Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
[TBL] [Abstract][Full Text] [Related]
2. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
Habila MA; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
BMC Womens Health; 2023 Nov; 23(1):640. PubMed ID: 38037005
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer and pap smear awareness and utilization of pap smear test among Federal civil servants in North Central Nigeria.
Hyacinth HI; Adekeye OA; Ibeh JN; Osoba T
PLoS One; 2012; 7(10):e46583. PubMed ID: 23049708
[TBL] [Abstract][Full Text] [Related]
5. Effect of social marketing on the knowledge, attitude, and uptake of pap smear among women residing in an urban slum in Lagos, Nigeria.
Olubodun T; Balogun MR; Odeyemi KA; Osibogun A; Odukoya OO; Banjo AA; Sonusi SE; Olubodun AB; Ogundele OOP; Dolapo DC
BMC Womens Health; 2022 Feb; 22(1):42. PubMed ID: 35164717
[TBL] [Abstract][Full Text] [Related]
6. Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.
Chigbu CO; Onyebuchi AK; Egbuji CC; Ezugwu EC
J Cancer Educ; 2015 Mar; 30(1):81-5. PubMed ID: 24980966
[TBL] [Abstract][Full Text] [Related]
7. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
8. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
[TBL] [Abstract][Full Text] [Related]
9. The need to incorporate routine cervical cancer counselling and screening in the management of HIV positive women in Nigeria.
Rabiu KA; Akinbami AA; Adewunmi AA; Akinola OI; Wright KO
Asian Pac J Cancer Prev; 2011; 12(5):1211-4. PubMed ID: 21875269
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
11. An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
Dim CC; Dim NR; Ezegwui HU; Ikeme AC
Medscape J Med; 2009; 11(1):19. PubMed ID: 19295940
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitude and practice of cervical cancer screening among women attending gynecology clinics in a tertiary level medical care center in southeastern Nigeria.
Mbamara SU; Ikpeze OC; Okonkwo JE; Onyiaorah IV; Ukah CO
J Reprod Med; 2011; 56(11-12):491-6. PubMed ID: 22195332
[TBL] [Abstract][Full Text] [Related]
13. Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.
Suurna M; Orumaa M; Ringmets I; Pärna K
BMC Womens Health; 2022 Dec; 22(1):545. PubMed ID: 36566176
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic and gynaecological factors that influence uptake of cervical cancer screening. A cross-sectional study in Calabar, Nigeria.
Ago BU; Efiok EE; Abeng SE
Afr Health Sci; 2022 Dec; 22(4):96-103. PubMed ID: 37092061
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
16. Rural Zulu women's knowledge of and attitudes towards Pap smears and adherence to cervical screening.
Godfrey MAL; Mathenjwa S; Mayat N
Afr J Prim Health Care Fam Med; 2019 Oct; 11(1):e1-e6. PubMed ID: 31588773
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
18. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
19. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
Okunade KS; Badmos KB; Soibi-Harry AP; Garba SR; Ohazurike EO; Ozonu O; Akanmu AS; Ogunsola FT; Abdulkareem FB; Anorlu RI
Acta Cytol; 2023; 67(3):248-256. PubMed ID: 36516788
[TBL] [Abstract][Full Text] [Related]
20. Perceived Barriers to Cervical Cancer Screening Uptake among Women of an Urban Community in South-Eastern Nigeria.
Ubah C; Nwaneri AC; Anarado AN; Iheanacho PN; Odikpo LC
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1959-1965. PubMed ID: 35763637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
